Dr. Humke is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
IGM Biosciences, Inc.
325 E Middlefield Rd
Mountain View, CA 94043Phone+1 650-352-6270- Is this information wrong?
Summary
- Dr. Eric Humke is an oncologist who now runs clinical trials for oncology patients. He received his undergraduate degree from Brown University, his M.D., Ph.D. degrees from University of Michigan Medical School (with Vishva Dixit), internal medicine residency at Barnes-Jewish Hospital in St. Louis, and his medical oncology fellowship from Stanford. Dr. Humke performed post-doctoral training with Matthew Scott and Rajat Rohatgi in Hedgehog signaling and was on the staff at Stanford before going on to Genentech as a medical director for 9 years. He is now the Vice President of Clinical Development, Apoptosis at IGM Biosciences.
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 2006 - 2011
- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2004 - 2006
- University of Michigan Medical SchoolClass of 2004
Certifications & Licensure
- CA State Medical License 2006 - 2022
Clinical Trials
Publications & Presentations
PubMed
- 12 citationsMultimeric Anti-DR5 IgM Agonist Antibody IGM-8444 Is a Potent Inducer of Cancer Cell Apoptosis and Synergizes with Chemotherapy and BCL-2 Inhibitor ABT-199.Beatrice Tien-Yi Wang, Tasnim Kothambawala, Ling Wang, Thomas J. Matthew, Susan E. Calhoun, Avneesh Saini, Maya Kotturi, Genevive Hernandez, Eric W. Humke, Marvin Pete...> ;Molecular Cancer Therapeutics. 2021 Oct 28
- 17 citationsAn open-label phase I dose-escalation study of the safety and pharmacokinetics of DMUC4064A in patients with platinum-resistant ovarian cancer.Joyce F. Liu, Howard A. Burris, Judy S. Wang, Lisa Barroilhet, Martin Gutierrez, Yulei Wang, Anjali Vaze, Renee Commerford, Stephanie Royer-Joo, Voleak Choeurng, Eric ...> ;Gynecologic Oncology. 2021 Oct 6
- 15 citationsPhase 1b study of anti-NaPi2b antibody-drug conjugate lifastuzumab vedotin (DNIB0600A) in patients with platinum-sensitive recurrent ovarian cancer.Kathleen N. Moore, Michael J. Birrer, Jim Marsters, Yulei Wang, YounJeong Choi, Stephanie Royer-Joo, Vanessa Lemahieu, Katy Armstrong, Julie Cordova, Divya Samineni, E...> ;Gynecologic Oncology. 2020 Jun 11
- Join now to see all
Press Mentions
- IGM Biosciences Appoints Eric Humke, M.D., Ph.D., as Vice President, Clinical Development, ApoptosisJanuary 7th, 2020
Professional Memberships
- Member
Hospital Affiliations
- Stanford Health CarePalo Alto, California
- Mills-Peninsula Medical CenterBurlingame, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: